Cargando…

Regulation of platelet count by erythropoiesis-stimulating agents – iron axis in hemodialysis patients

Higher doses of erythropoiesis-stimulating agents (ESAs) contribute to atherothrombotic cardiovascular disease in hemodialysis (HD) patients. Thrombocytosis is associated with increased mortality in ESA-treated HD patients. We investigated variables affecting platelet count and its variability (plat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koike, Kiyomi, Fukami, Kei, Kawaguchi, Atsushi, Shimamatsu, Kazumasa, Yamagishi, Sho-ichi, Okuda, Seiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822794/ https://www.ncbi.nlm.nih.gov/pubmed/27099526 http://dx.doi.org/10.2147/IJNRD.S98196

Ejemplares similares

Effects of switching from oral administration to intravenous injection of l-carnitine on lipid metabolism in hemodialysis patients
por: Fukami, Kei, et al.
Publicado: (2014)

Involvement of Iron-Evoked Oxidative Stress in Smoking-Related Endothelial Dysfunction in Healthy Young Men
por: Fukami, Kei, et al.
Publicado: (2014)

Serum Levels of Growth Differentiation Factor 11 Are Independently Associated with Low Hemoglobin Values in Hemodialysis Patients
por: Yamagishi, Sho-ichi, et al.
Publicado: (2016)

Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015)

Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients
por: Shimamatsu, Kazumasa
Publicado: (2014)

Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis
por: Honda, Hirokazu, et al.
Publicado: (2016)

A Safe and Easy Introduction of Darbepoetin-Alpha in Patients Receiving Maintenance Hemodialysis and Epoetin Monotherapy: A “Half-and-Half” Combination Therapy()
por: Shimamatsu, Kazumasa, et al.
Publicado: (2013)

Iron Mining for Erythropoiesis
por: Correnti, Margherita, et al.
Publicado: (2022)

Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
por: Fukami, Kei, et al.
Publicado: (2014)

Changes of biomarkers for erythropoiesis, iron metabolism, and FGF23 by supplementation with roxadustat in patients on hemodialysis
por: Yoshida, Shunsuke, et al.
Publicado: (2023)

Relationship between platelet count and hemodialysis membranes
por: Nasr, Rabih, et al.
Publicado: (2013)

Platelet reactivity and platelet count in women with iron deficiency treated with intravenous iron
por: Elstrott, Benjamin K., et al.
Publicado: (2022)

Erythropoiesis and iron metabolism in Hodgkin's disease.
por: Al-Ismail, S., et al.
Publicado: (1979)

Erythropoiesis and Iron Sulfur Cluster Biogenesis
por: Ye, Hong, et al.
Publicado: (2010)

Crosstalk between Erythropoiesis and Iron Metabolism
por: Rivella, Stefano, et al.
Publicado: (2010)

Crosstalk between Iron Metabolism and Erythropoiesis
por: Li, Huihui, et al.
Publicado: (2010)

Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
por: Ishibashi, Yuji, et al.
Publicado: (2014)

L-Carnitine Supplementation Improves Self-Rating Depression Scale Scores in Uremic Male Patients Undergoing Hemodialysis
por: Tashiro, Kyoko, et al.
Publicado: (2017)

Efficacy of Combination Therapy with Telmisartan Plus Amlodipine in Patients with Poorly Controlled Hypertension
por: Bekki, Hisatoshi, et al.
Publicado: (2010)

Use of erythropoiesis-stimulating agents in obese hemodialysis patients
por: Park, Sun-Hee
Publicado: (2018)

Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort study
por: Yessayan, Lenar, et al.
Publicado: (2014)

Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients
por: Rafieian-Kopaie, Mahmoud, et al.
Publicado: (2012)

Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury
por: Nakayama, Yosuke, et al.
Publicado: (2014)

DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
por: Kaida, Yusuke, et al.
Publicado: (2013)

Iron Loading and Overloading due to Ineffective Erythropoiesis
por: Tanno, Toshihiko, et al.
Publicado: (2010)

The relationship between systemic iron homeostasis and erythropoiesis
por: Rishi, Gautam, et al.
Publicado: (2017)

Imbalance of erythropoiesis and iron metabolism in patients with thalassemia
por: Huang, Yumei, et al.
Publicado: (2019)

Effect of hepatitis C virus infection on erythropoiesis in patients on hemodialysis
por: Saifan, Chadi, et al.
Publicado: (2013)

Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Yasukawa, Minoru, et al.
Publicado: (2022)

Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients
por: Lee, Yu-Ting, et al.
Publicado: (2022)

Comment on: Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients
por: Baradaran, Azar
Publicado: (2012)

A Retrospective Study on Erythropoiesis Stimulating Agent Dose Reducing Potential of an Anti‐Platelet Activation Membrane Dialyzer in Hemodialysis Patients
por: Kakuta, Takatoshi, et al.
Publicado: (2018)

Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
por: Suttorp, Marit M, et al.
Publicado: (2013)

Biomarkers of Hypochromia: The Contemporary Assessment of Iron Status and Erythropoiesis
por: Urrechaga, Eloísa, et al.
Publicado: (2013)

A biomathematical model of human erythropoiesis and iron metabolism
por: Schirm, Sibylle, et al.
Publicado: (2020)

Normal and dysregulated crosstalk between iron metabolism and erythropoiesis
por: Ginzburg, Yelena, et al.
Publicado: (2023)

An Increase in Mean Platelet Volume/Platelet Count Ratio Is Associated with Vascular Access Failure in Hemodialysis Patients
por: Shin, Dong Ho, et al.
Publicado: (2017)

Resistance to Erythropoiesis-Stimulating Agents Is Associated with Arterial Microcalcification in Early Hemodialysis Patients
por: Won, Hye Sung, et al.
Publicado: (2014)

Roxadustat treatment for erythropoiesis-stimulating agent-hyporesponsive anemia in maintenance hemodialysis patients
por: Song, Jie, et al.
Publicado: (2023)

β-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
por: Melchiori, Luca, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_t0nfq85iord6mpv3qbpdkk8tbi